Response Evaluation of Newly Diagnosed EGFR Mutated NSCLC in Tertiary Referral Cancer Center in Jakarta-Indonesia

被引:0
|
作者
Amelia, D. A. R. [1 ]
Irawan, C. [1 ]
Rajabto, W. [1 ]
Kurniawan, A. [1 ,2 ]
Sari, C. [1 ]
Nasution, M. A. [1 ]
Djatnika, D. [1 ]
Priantono, D. [1 ]
Ariyanti, F. [1 ]
Wisman, B. A. [1 ]
Purlikasari, N. P. [1 ]
Dharmaraja, F. [2 ]
Nathalia, C. [2 ]
机构
[1] Univ Indonesia, Fac Med, Jakarta, Indonesia
[2] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia
关键词
non-small cell lung cancer; EGFR mutation; targeted therapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP12.01-69
引用
收藏
页码:S669 / S669
页数:1
相关论文
共 50 条
  • [31] Squamous carcinoma coexistent with teratoma of ovary: A clinicopathological study of 12 cases diagnosed over a 10-year period at a tertiary cancer referral center
    Rekhi, Bharat
    Parikh, Pinki
    Deodhar, Kedar K.
    Menon, Santosh
    Maheshwari, Amita
    Kerkar, Rajendra
    Gupta, Sudeep
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (01) : 211 - 215
  • [32] Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
    Kate, Shruti
    Chougule, Anuradha
    Joshi, Amit
    Noronha, Vanita
    Patil, Vijay
    Dusane, Rohit
    Solanki, Leena
    Tiwrekar, Priyanka
    Trivedi, Vaishakhi
    Prabhash, Kumar
    LUNG CANCER-TARGETS AND THERAPY, 2019, 10 : 1 - 10
  • [33] EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review
    Enting, D.
    Januszewski, A.
    Benepal, T.
    LUNG CANCER, 2012, 75 : S5 - S5
  • [34] Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center
    Winkler, Leah-Sophie
    Haderlein, Marlen
    Semrau, Sabine
    Putz, Florian
    Hoefler, Daniel
    Mueller, Sarina K.
    Iro, Heinrich
    Kesting, Marco
    Fietkau, Rainer
    Schubert, Philipp
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Erlotinib (E) in non small cell lung cancer (NSCLC) patients (pts) ≥75 years old with comorbidities (cM): Experience at a tertiary referral center.
    Syrigos, Konstantinos N.
    Sarris, Evangelos
    Strimpakos, Alexios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India
    Tiwari, Atul
    Singh, Ajay Kumar
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Shah, Minit J.
    Shah, Darshit
    Jobanputra, Kunal
    Trikha, Mehak
    Ubharay, Ahmad
    Yadav, Shashikant
    Majumdar, Anuradha
    Chandrani, Pratik
    Kumar, Rajiv K.
    Pai, Trupti
    Janu, Amit
    Purandare, Nilendu
    Prabhash, Kumar
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [37] iTARGET: A phase II trial to assess the response to gefitinib in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) tumors
    Sequist, L. V.
    Martins, R. G.
    Spigel, D.
    Grunberg, S. M.
    Janne, P. A.
    McCollum, D.
    Spira, A.
    Evans, T.
    Johnson, B. E.
    Lynch, T. J., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] A Pilot Study to Evaluate Prevalence of Wilms Tumor-1 (WT1) Gene Mutation in Newly Diagnosed Cases of Acute Myeloid Leukemia from a Tertiary Referral Center in India
    Tanwar, Pranay
    Haider, Imran
    Ranjan, Amar
    Bakhshi, Sameer
    Kumar, Lalit
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S212 - S212
  • [39] Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011
    Gomes, Marisa Z. R.
    Mulanovich, Victor E.
    Jiang, Y.
    Lewis, Russell E.
    Kontoyiannis, Dimitrios P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 865 - 873
  • [40] THE EFFICACY OF METHOTREXATE MONOTHERAPY STRATEGY CHOSEN AS FIRST-LINE DMARD THERAPY IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS: RETROSPECTIVE EVALUATION OF SINGLE TERTIARY CENTER EXPERIENCE
    Erdik, N.
    Guneysu, C. Arslanturk
    Turk, S. M.
    Yavuzbilge, G.
    Karatas, D.
    Unan, M. Kalcik
    Gonullu, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1429 - 1430